Source: ERJ Open Res, 7 (4) 00467-2021; 10.1183/23120541.00467-2021



Rating:

Share or cite this content

Citations should be made in the following way:
John R. Hurst, S. Hamza Abbas, Heba M. Bintalib, Tiago M. Alfaro, Ulrich Baumann, Siobhan O. Burns, Alison Condliffe, Jesper R. Davidsen, Børre Fevang, Andrew R. Gennery, Filomeen Haerynck, Joseph Jacob, Stephen Jolles, Olivia Lamers, Anne Bergeron, Marion Malphettes, Véronique Meignin, Cinzia Milito, Tomas Milota, Martine Pergent, Antje Prasse, Isabella Quinti, Elisabetta Renzoni, Anna Sediva, Daiana Stolz, Bas Smits, Friedolin Strauss, Annick A.J.M. van de Ven, Joris van Montfrans, Klaus Warnatz. Granulomatous–lymphocytic interstitial lung disease: an international research prioritisation. ERJ Open Res, 7 (4) 00467-2021; 10.1183/23120541.00467-2021

Member's Comments

No comment yet.

Related content which might interest you: Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019 Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options Year: 2021 Chosen lymphocytic subpopulations in the course of interstitial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001 A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation Source: Eur Respir J, 55 (4) 1901760; 10.1183/13993003.01760-2019 Year: 2020 Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology Source: Eur Respir Rev 2013; 22: 117-123 Year: 2013 Acute fibrinous and organizing pneumonia: A retrospective study Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Source: Eur Respir Rev 2012 21: 355-361 Year: 2012 ERS guidelines on treatment of sarcoidosis Source: ERS webinar 2021: ERS guidelines on treatment of sarcoidosis Year: 2021 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 Lymphocytic interstitial pneumonia – a rare underestimated entity of interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 257s Year: 2007 Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 B-cell infiltration varies among patients with interstitial lung diseases Source: International Congress 2016 – ILD pathogenesis Year: 2016 Interstitial lung diseases: a clinical update Source: Eur Respir J 2001; 18: 1S Year: 2001 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group Source: Eur Respir J 2005; 26: Suppl. 49, 500s Year: 2005 Clinical management of the idiopathic interstitial pneumonias: an example of an integrated approach to interstitial lung diseases Source: Annual Congress 2006 - PG8 - Interstitial lung diseases: idiopathic interstitial pneumonias Year: 2006 Unclassifiable interstitial lung disease: a pathologist's perspective Source: Eur Respir Rev, 27 (147) 170132; 10.1183/16000617.0132-2017 Year: 2018